Semaglutide is a GLP-1 medication that mimics the action of the naturally occurring glucagon-like peptide-1 hormone to suppress appetite, increase insulin secretion, decrease hunger cravings, and reduce calorie intake
In addition, it is crucial for the functioning of the central nervous system, along with the absorption and metabolism of fats and carbohydrates
They work best as part of a comprehensive plan that includes proper nutrition and physical activity
Stopping B12 treatment is as dangerous, albeit more slowly, as stopping anticoagulation in patients with AF
Acute pancreatitis, including fatal and non-fatal hemorrhagic or necrotizing pancreatitis, has been observed in patients treated with GLP-1 receptor agonists, including semaglutide
BPC-157 presents unique considerations in this regard